Acadian Asset Management LLC Celldex Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$9.65 - $15.19 $2.2 Million - $3.46 Million	-228,015 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$1.61 - $13.41 $113,720 - $947,201	-70,634 Reduced 23.65%	228,015 $2.96 Million
Q1 2020 May 11, 2020	BUY	$1.55 - $3.07 $78,403 - $155,289	50,583 Added 20.39%	298,649 $496,000
Q4 2019 Feb 06, 2020	SELL	$2.11 - $2.8 $17,390 - $23,077	-8,242 Reduced 3.22%	248,066 $553,000
Q3 2019 Nov 07, 2019	SELL	$2.05 - $2.75 $23,060 - $30,934	-11,249 Reduced 4.2%	256,308 $547,000
Q2 2019 Aug 08, 2019	BUY	$2.43 - $5.09 $292,861 - $613,441	120,519 Added 81.96%	267,557 $718,000
Q1 2019 May 09, 2019	BUY	$3.45 - $10.35 $507,281 - $1.52 Million	147,038 New	147,038 $723,000

195

63.5M

206K

176K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.43B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.